Racial differences in trends of serious hypoglycemia among higher risk older adults in US Veterans Health Administration, 2004-2015: Relationship to comorbid conditions, insulin use, and hemoglobin A1c level.


Journal

Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583

Informations de publication

Date de publication:
03 2020
Historique:
received: 02 08 2019
revised: 25 10 2019
accepted: 27 10 2019
pubmed: 18 1 2020
medline: 31 7 2021
entrez: 18 1 2020
Statut: ppublish

Résumé

To evaluate temporal trends in racial/ethnic groups in rates of serious hypoglycemia among higher risk patients dually enrolled in Veterans Health Administration and Medicare fee-for-service and assess the relationship(s) between hypoglycemia rates, insulin/secretagogues and comorbid conditions. Retrospective observational serial cross-sectional design. Patients were ≥65 years receiving insulin and/or secretagogues. The primary outcome was the annual (period prevalence) rates (2004-2015), per 1000 patient years, of serious hypoglycemic events, defined as hypoglycemic-related emergency department visits or hospitalizations. Subjects were 77-83% White, 7-10% Black, 4-5% Hispanic, <2% women; 38-58% were ≥75 years old; 72-75% had ≥1 comorbidity. In 2004-2015, rates declined from 63.2 to 33.6(-46.9%) in Blacks; 29.7 to 20.3 (-31.6%) in Whites; and 41.8 to 29.6 (-29.3%) in Hispanics. The Black-White rate differences narrowed regardless of insulin use, hemoglobin A1c level, and frequency and various combinations of comorbid conditions. Among insulin users, the Black-White contrast decreased from 34.7 (98.5 vs. 63.8) in 2004 to 13.2 (43.6 vs. 30.4) in 2015; in non-insulin users, the contrast was 25.7 (44.1 vs. 18.4) in 2004 and 10.1 (18.9 vs. 8.8) in 2015. Marked declines in serious hypoglycemia events occurred across race, medications, and comorbidities, suggesting significant changes in clinical practice.

Identifiants

pubmed: 31948777
pii: S1056-8727(19)30873-6
doi: 10.1016/j.jdiacomp.2019.107475
pmc: PMC9880802
mid: NIHMS1619300
pii:
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
Insulin 0

Types de publication

Historical Article Journal Article Observational Study Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107475

Subventions

Organisme : HSRD VA
ID : I01 HX001601
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

J Med Econ. 2016 Sep;19(9):852-7
pubmed: 27074526
Ann Intern Med. 2017 Jul 18;167(2):95-102
pubmed: 28605777
Diabetes Care. 2004 May;27 Suppl 2:B10-21
pubmed: 15113777
J Manag Care Spec Pharm. 2015 Mar;21(3):243-53
pubmed: 25726033
BMJ. 2010 Jan 08;340:b5444
pubmed: 20061360
Health Serv Res. 2006 Apr;41(2):564-80
pubmed: 16584465
Diabetes Care. 2016 Mar;39(3):363-70
pubmed: 26681726
Diabetes Care. 2016 Aug;39(8):1458-61
pubmed: 27457636
J Diabetes Complications. 2018 Apr;32(4):373-378
pubmed: 29496364
Public Health Rep. 2011 Jul-Aug;126(4):460-71
pubmed: 21800741
J Diabetes Complications. 2017 May;31(5):869-873
pubmed: 28319006
JAMA. 2011 Feb 16;305(7):709-10
pubmed: 21325188
BMC Endocr Disord. 2008 Apr 01;8:4
pubmed: 18380903
Diabetes Care. 2017 Apr;40(4):468-475
pubmed: 27659408
JAMA Intern Med. 2014 Feb 1;174(2):259-68
pubmed: 24322626
Diabetes Care. 2017 Dec;40(12):1651-1660
pubmed: 28716781
Prehosp Emerg Care. 2017 Nov-Dec;21(6):767-772
pubmed: 28641035
Endocr Pract. 2016 Feb;22(2):196-204
pubmed: 26492544
JAMA Intern Med. 2014 Jul;174(7):1116-24
pubmed: 24838229
Lancet Diabetes Endocrinol. 2016 Aug;4(8):677-685
pubmed: 27293218
JAMA Intern Med. 2016 Jul 1;176(7):969-78
pubmed: 27273792
Diabetes Care. 2012 Apr;35(4):787-93
pubmed: 22374637
Clin Diabetes. 2018 Apr;36(2):120-127
pubmed: 29686450
JAMA Intern Med. 2017 Oct 1;177(10):1461-1470
pubmed: 28828479

Auteurs

Chin-Lin Tseng (CL)

Department of Veterans Affairs-New Jersey Health Care System, East Orange, NJ, USA. Electronic address: chin-lin.tseng@va.gov.

David C Aron (DC)

Louis Stokes Department of Veterans Affairs Medical Center, Cleveland, OH, USA; School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Orysya Soroka (O)

Department of Veterans Affairs-New Jersey Health Care System, East Orange, NJ, USA.

Shou-En Lu (SE)

Department of Veterans Affairs-New Jersey Health Care System, East Orange, NJ, USA; Department of Biostatistics and Epidemiology, Rutgers University - School of Public Health, Piscataway, NJ, USA.

Catherine E Myers (CE)

Department of Veterans Affairs-New Jersey Health Care System, East Orange, NJ, USA; Department of Physiology, Pharmacology, & Neuroscience, Rutgers University-New Jersey Medical School, Newark, NJ, USA.

Leonard M Pogach (LM)

Department of Veterans Affairs-New Jersey Health Care System, East Orange, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH